- FREE SHIPPING OVER 120CAD
- Cheapest Weed Online in Canada
- Guaranteed Shipping
In the wake of the unprecedented coronavirus disease (COVID-19) outbreak caused by SARS-CoV-2, the relevance of cannabis use and its implications on health have gained prominence. As we continue to grapple with the aftermath of the coronavirus disease (COVID-19) and its impact on public health, it becomes imperative to explore the potential implications of cannabis use in this context.
Recent studies have shed light on the relationship between cannabis consumption and COVID-19 outcomes. Cannabis users, particularly regular cannabis users, may face multiple clinical risks when it comes to infectious diseases. The risk factors include cannabis smoking and vaping, which can have respiratory effects that affect the immune system, as well as tobacco use and previous smoking history.
In this blog post, we will delve into the key points that have emerged from studies exploring the relationship between cannabis use and COVID-19.
Recent data on cannabis consumption in Canada reveal intriguing trends and changes, shedding light on the evolving landscape of cannabis use. Notably, there is a disparity between males and females, with 30% of males reporting higher past-year cannabis use compared to 25% of females.
This distinction raises questions about potential shifts in how people are using cannabis, as well as changes in the reasons for its consumption. Reported past 12-month cannabis use increased among females from 2021 to 2022, while it remained unchanged among males.
This gender-based difference prompts a closer examination of the role of cannabis in managing post-pandemic stress and the potential impact on various demographics.
The COVID-19 pandemic brought about a substantial impact on the cannabis industry, influencing various aspects, from regulations to consumer behaviour. As cannabis users grappled with the uncertainty of the novel coronavirus, multiple clinical risks came to the forefront.
Recent retrospective cohort analyses indicated that cannabis smoking might pose higher risks for COVID-19 patients. Furthermore, cannabis consumption, mainly smoking, raised concerns due to its potential respiratory effects.
As the World Health Organization noted the immunomodulatory properties of cannabinoids, further investigations were prompted. Nevertheless, cannabis was recognized as an essential business in some areas, emphasizing its significance during the pandemic. Changes in regulations and sales occurred as the industry adapted to the evolving landscape.
Substance use and drug overdoses have surged in the United States since the onset of the COVID-19 pandemic, posing a significant public health concern.
A study conducted by the National Institute on Drug Abuse (NIDA), analyzing electronic health records of over 73 million patients, revealed that individuals with substance use disorders were 1.5 times more susceptible to COVID-19 infection and more likely to experience severe complications, including hospitalization and death.
The United States has witnessed a steady rise in drug overdose deaths since the 1980s. This alarming trend intensified during the COVID-19 pandemic, with overdose deaths skyrocketing by over 30% in 2020 and continuing to escalate in 2021.
Factors associated with the pandemic, such as social isolation, increased stress levels, individuals using drugs alone, and diminished access to treatment and services, are believed to have exacerbated this trend. However, further research is warranted to fully comprehend the intricate link between the pandemic and overdose deaths.
The post-pandemic cannabis market in 2023 presents a promising landscape for economic opportunities. With the evolving attitudes and regulatory changes surrounding cannabis, the industry is poised for significant growth and investment.
As the world adapts to the new normal, the cannabis market stands out as a sector with vast potential. Recent developments and products, including innovative strains, cannabis-based treatments, and consumption methods, are continuously emerging.
These offerings provide diverse avenues for entrepreneurs and investors to explore the cannabis industry. This dynamic industry offers not only the potential for financial success but also the chance to contribute to the ongoing research and development of cannabis-based products.
Recent research findings have unveiled promising breakthroughs that highlight the potential of cannabis in addressing various health concerns. One particularly intriguing aspect is its capacity to offer relief in the realm of mental health and wellness post-pandemic.
The world witnessed the importance of mental well-being during the crisis, and cannabis is being studied for its potential to help individuals cope with the aftermath. As we continue to explore the therapeutic applications of cannabis, it becomes clear that the substance possesses immunomodulatory properties.
Additionally, its potential to modulate the body’s response to infectious diseases could hold substantial promise in the treatment field. The evolving landscape of medical cannabis is likely to bring better outcomes and improved well-being for a multitude of patients.
A recent study has found that cannabis users who contracted COVID-19 had significantly better outcomes and reduced mortality compared to people who do not use marijuana.
The study, which analyzed data from over 320,000 hospitalized patients, found that cannabis users were less likely to die from COVID-19. In addition, further investigation found that marijuana users are less likely to be admitted to the intensive care unit (ICU), and less likely to require mechanical ventilation.
Researchers at the University of Oregon have also explored cannabis as a potential treatment for COVID-19, suggesting that its anti-inflammatory and anti-viral properties may play a role in its positive effects on disease outcomes.
While these findings are promising, it is important to note that the study is observational, meaning that it does not prove that cannabis use causes better COVID-19 outcomes. It is possible that other factors, such as lifestyle or underlying health conditions, could explain the association between cannabis use and COVID-19 outcomes.
Yes, Cannabis remains essential even after the coronavirus pandemic. The reasons behind this designation are grounded in both medical and economic factors. For medical cannabis users, it plays a crucial role in managing various conditions, offering relief from symptoms, and improving their quality of life.
Furthermore, the economic aspect cannot be ignored, as the cannabis industry has significantly contributed to job creation, tax revenue, and investment opportunities. As more research unfolds, the potential therapeutic benefits of Cannabis are becoming increasingly evident.
This dual significance in terms of health and the economy solidifies Cannabis as an essential element in the post-pandemic world, continuing to serve the needs of both individuals and society at large.
In 2023, the cannabis industry is witnessing dynamic economic and market trends, marking its resilience post-COVID-19. The landscape has evolved significantly, with emerging opportunities and challenges for cannabis businesses.
As societal attitudes towards cannabis continue to shift, legalization efforts have gained momentum in various regions, expanding the market’s horizons.
The demand for innovative cannabis products and therapies is growing, creating opportunities for entrepreneurs and investors. However, challenges such as evolving regulations, market saturation, and competition also pose considerations for industry players.
In the post-COVID era, the landscape of cannabis has undergone notable shifts. With changing perspectives and legal frameworks, the demand for cannabis has been on the rise. People are exploring the potential benefits of cannabis in addressing various health and wellness concerns that have emerged during the pandemic.
This surge in interest has not only impacted cannabis users but also shaped the economic landscape of the cannabis industry, offering new opportunities and challenges.
I’m Zoey Roy, a Cannabis Compliance Specialist and Cannabis Activist. I am experienced in guiding individuals and businesses through complex cannabis regulations. With a Bachelor’s degree in Research from McGill University, I’ve worked at Neptune Wellness for 4 years as a senior researcher. Now I serve as a Cannabis Industry Analyst at Tilray Brands, Inc. I provide essential support in ensuring compliance, educating clients, and facilitating legal requirements. My expertise extends to marketing and laboratory skills, making me a well-rounded professional in the field.
The process of weed delivery typically involves the following steps all over Canada:
Ensure compliance with legal regulations surrounding cannabis in Canada and consume responsibly. Enjoy the convenience of weed delivery from Save on Greens.
Save on Greens weed delivery in Canada offers several advantages that make it a popular choice among customers:
When choosing Save on Greens for your weed delivery in Canada, you can enjoy a convenient, affordable, and reliable service that prioritizes customer satisfaction.
Yes, all your information is 100% secure. We don’t share your information with anybody.
Yes, weed delivery is legal in Canada. Individuals are allowed to ship and receive cannabis within the country. However, there are specific delivery requirements that need to be followed, including ensuring that the contents, packaging, and labeling of the shipments comply with all applicable legislation and regulations. It’s important to adhere to these guidelines to ensure the legal and proper delivery of cannabis products in Canada.
The amount of weed you can order for delivery depends on the product type. For recreational cannabis, including extracts, topicals, and edibles, the shipping limit is 30 grams. Medical cannabis orders can be up to 30 times the patient’s daily prescription.
If you’re ordering cannabis plants, the limit is 4 plants per household, except in Manitoba and Quebec where it is prohibited.
However, there is no limit on the amount of cannabis seeds you can order for delivery, except in Manitoba and Quebec where it is also prohibited. It’s important to be aware of these limits to ensure compliance with the regulations when placing your weed delivery order.
Save On Greens an online weed dispensary in Canada with fair prices and fast delivery. We know that being on a tight budget is real! That’s why we’re all about making sure our prices won’t burn a hole in your wallet.